您现在位置： -医药产业>> 搜索结果
Tags名称：Cabozantinib,共找到33条记录，执行时间：0.313
| ·欧批准Cabometyx（cabozantinib）作为肝癌... | 2018-11-19 07:34:16 |
| ·Cabozantinib进行甲状腺癌3期试验 | 2018-10-12 19:25:54 |
| ·欧批准Cabometyx(cabozantinib)作为肾癌... | 2018-05-18 11:48:27 |
| ·Cabozantinib肝细胞癌3期试验成功 | 2018-01-19 11:57:31 |
| ·美批准Cabometyx(cabozantinib)作为肾癌... | 2017-12-22 12:29:05 |
| ·Cabozantinib肝细胞癌3期试验获肯定结果 | 2017-10-17 14:36:57 |
| ·Cabometyx(cabozantinib)申请作为肾癌一... | 2017-08-17 17:05:30 |
| ·CHMP支持Cabozantinib与lenvatinib用... | 2016-07-26 14:29:49 |
| ·美批准Cabometyx(cabozantinib)用于肾细... | 2016-04-26 15:45:06 |
| ·Cabozantinib申请用于晚期肾细胞癌 | 2015-12-30 11:42:10 |
| ·Cabozantinib获肾细胞癌突破性疗法资格 | 2015-08-28 15:28:59 |
| ·Cabozantinib肾细胞癌3期试验获肯定结果 | 2015-07-22 14:43:07 |
| ·Cabozantinib一项非小细胞肺癌2期试验获肯定结果 | 2015-06-03 15:31:08 |
| ·Cabozantinib一项前列腺癌3期试验失败 | 2014-12-03 14:43:47 |
| ·新型分子靶向抗癌药物卡博替尼 | 2014-07-04 11:02:25 |
| ·CHMP支持Cometriq(cabozantinib)用于... | 2013-12-25 14:58:33 |
| ·Cabozantinib甲状腺髓样癌3期结果公布 | 2013-09-16 15:16:42 |
| ·Cabozantinib进行肾细胞癌3期试验 | 2013-06-04 14:10:06 |
| ·Cabozantinib公布前列腺癌中期试验结果 | 2012-12-10 11:35:35 |
| ·欧洲接受Cometriq(cabozantinib)甲状腺髓... | 2012-12-03 10:48:47 |
| ·美批准Cometriq(cabozantinib)用于甲状腺... | 2012-11-30 11:43:52 |
| ·Cabozantinib申请用于甲状腺髓样癌 | 2012-05-31 12:07:23 |
| ·Cabozantinib进行难控型肾细胞癌试验 | 2012-02-07 10:07:38 |
| ·Exelixis开展前列腺癌骨转移3期试验 | 2011-11-03 07:55:38 |
| ·Cabozantinib计划进行前列腺癌骨转移3期试验 | 2011-11-03 10:00:58 |
| ·Cabozantinib甲状腺髓样癌3期试验获肯定结果 | 2011-10-31 07:35:38 |
| ·Cabozantinib甲状腺髓样癌3期试验获肯定结果 | 2011-10-31 10:21:21 |
| ·Cabozantinib甲状腺癌3期试验获肯定结果 | 2011-07-08 07:58:41 |
| ·抗癌药Cabozantinib开发进展 | 2011-07-08 11:26:01 |
| ·Cabozantinib前列腺癌骨转移中期试验获肯定结果 | 2011-06-08 10:28:46 |
| ·Cabozantinib中期试验对多种癌症有效 | 2011-05-19 12:34:49 |
| ·Cabozantinib获甲状腺髓样癌罕用药授权 | 2011-01-13 08:41:30 |
| ·Cabozantinib甲状腺髓样癌3期试验中 | 2011-01-13 12:35:21 |
